Springer Nature raises minimum revenue growth forecast to 6% after 6.3% increase
Key Facts
Springer Nature said on November 17 that underlying revenue rose 6.3% in the first nine months of 2026 to €1,469.3 million, compared with €1,428.7 million in the same period of 2025. In light of the performance, the company raised the floor of its forecast for underlying revenue growth in the financial year to 6%, from August guidance for growth of around 6%. It maintained its target for an improvement of at least 30 basis points in the underlying adjusted operating profit margin. In March, the company had forecast underlying revenue growth of between 5% and 6% and an improvement of around 30 basis points in the margin. The forecast revision raises the floor for annual growth as underlying revenue growth in the reported period exceeded 6%.
Group adjusted operating profit was €427.8 million, compared with €408.3 million a year earlier, representing underlying growth of 7.7%. The underlying adjusted operating profit margin improved by 36 basis points in the first nine months, exceeding the company’s minimum target for the full year. The research segment was the largest contributor to this performance, with underlying revenue up 7.4% to €1,145.4 million, compared with €1,112.6 million in the same period. The company said research revenue growth was led by its journals portfolio. The segment’s adjusted operating profit also rose 8.4% on an underlying basis to €369 million from €351.5 million, driven by operating leverage and efficiency measures, and growing faster than its revenue.
The number of articles published by the company increased by around 12% in the first nine months, compared with estimated market growth of around 8% for the same period, according to Springer Nature estimates. The chief executive said the momentum was linked to “our leadership in open access, the use of AI-powered tools and our ongoing investments.” Strength in journals included fully open-access brands, as well as Nature and Springer. The company signed 23 new transformative agreements during the period, bringing the total to 105 at the end of September, covering more than 4,500 institutions. It said more than 62% of submissions were processed through its AI-powered SNAPP platform.
Results in the other segments varied, with underlying education revenue up 4.4% to €190.2 million from €181.1 million a year earlier. The company attributed education growth to performance in Argentina, South Africa and Poland, partly offset by tougher market conditions in Mexico and Spain. The health segment posted underlying growth of 0.5%, despite reported revenue falling to €134.9 million from €135.9 million. The segment benefited from stable advertising spending, offset by weaker performance in its events business in Germany, Austria and Switzerland. The company’s figures show that education and health grew more slowly than the research segment in the first nine months.
Free cash flow rose by €69.1 million to €243.6 million in the first nine months, which the company attributed to improved operating performance, one-off proceeds from the settlement of currency derivatives and lower interest payments. Net financial debt was €1,200 million on September 30. The net debt to adjusted earnings before interest, taxes, depreciation and amortization ratio stood at 1.6 times on the same date. The company said the ratio was within its target range of 1.5 to 2.0 times. It said it continued to reduce leverage during the period.
The share price did not track the raised outlook, falling by as much as 4% during the November 17 session after erasing its morning gains, according to Investing.com coverage. The report said third-quarter results exceeded analyst estimates, but the company did not provide a comparison between adjusted operating profit and those estimates in its announcement. In an earlier update in August, management had raised its forecast for underlying revenue growth to around 6%, while targeting an improvement of at least 30 basis points in the margin. The company also said its experimental Nature Research Assistant had exceeded 25,000 users at the time results were published, with its launch planned for early 2027. It scheduled a call for investors and analysts on November 17 at 14:00 Central European Time.